Z-2184-2012 Class II Terminated

Recalled by AGFA Corp. — Greenville, SC

FDA device recall Z-2184-2012 was initiated by AGFA Corp. on Jul 27, 2012 and is designated Class II. Reason for recall: Content entered into the "Conclusions" free text box on the Report Writer screen was not represented on the final printed report. The recall status is terminated (terminated Jan 13, 2015). Affected quantity: 280.

Recall details

Product Type
Devices
Report Date
Aug 22, 2012
Initiation Date
Jul 27, 2012
Termination Date
Jan 13, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
280

Product description

IMPAX Cardiovascular (CV) Reporting Reporting tool used for structured reporting and structured report outputs (including XML style sheet customization and PDF)

Reason for recall

Content entered into the "Conclusions" free text box on the Report Writer screen was not represented on the final printed report.

Distribution pattern

Worldwide Distribution - USA (nationwide) and Canada

Code information

Model # L9M2100 - All Software versions of IMPAX CV Reporting

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2184-2012
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for AGFA Corp.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for Z-2184-2012. Report a data issue: hello@regdatalab.com.